Cargando…

Developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome

BACKGROUND: Fetoscopic laser coagulation of placental anastomoses reverses the pathological process in twin-to-twin transfusion syndrome, thereby increasing survival, but there are a paucity of studies addressing long-term neurodevelopmental outcome of survivors. This study aimed to ascertain the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzys, Angela, Reid, Susan M., Bolch, Christie, Reddihough, Dinah S., Teoh, Mark, Palma-Dias, Ricardo, Fung, Alison, Cole, Stephen, Hodges, Ryan, Fahey, Michael, Walker, Susan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540356/
https://www.ncbi.nlm.nih.gov/pubmed/37770827
http://dx.doi.org/10.1186/s12884-023-05997-5
_version_ 1785113698104246272
author Guzys, Angela
Reid, Susan M.
Bolch, Christie
Reddihough, Dinah S.
Teoh, Mark
Palma-Dias, Ricardo
Fung, Alison
Cole, Stephen
Hodges, Ryan
Fahey, Michael
Walker, Susan P.
author_facet Guzys, Angela
Reid, Susan M.
Bolch, Christie
Reddihough, Dinah S.
Teoh, Mark
Palma-Dias, Ricardo
Fung, Alison
Cole, Stephen
Hodges, Ryan
Fahey, Michael
Walker, Susan P.
author_sort Guzys, Angela
collection PubMed
description BACKGROUND: Fetoscopic laser coagulation of placental anastomoses reverses the pathological process in twin-to-twin transfusion syndrome, thereby increasing survival, but there are a paucity of studies addressing long-term neurodevelopmental outcome of survivors. This study aimed to ascertain the presence of neurodevelopmental disabilities in child survivors of monochorionic pregnancies managed by placental laser photocoagulation in the Australian state of Victoria. METHODS: All pregnancies undergoing placental laser photocoagulation with the Victorian Fetal Therapy Service between 2006–2017 were included. Information on each surviving child, including demographics, perinatal course, and developmental progress was collected from parents, and consent was sought to complete the Child Behaviour Checklist. Interviewers evaluated whether this information was consistent with a diagnosis of any of 14 neurodevelopmental conditions. A three-tiered outcome measure was allocated for each child: (1) unimpaired or developmentally normal, (2) mild or moderate neurological impairment, or (3) severe neurological impairment. Clinical predictors for adverse outcome were identified. RESULTS: Of 116 pregnancies (113 twin, 3 triplet), 96 (83%) resulted in 1 + surviving fetuses. 57/113 (50%) twin pregnancies resulted in 2 survivors, 36 (32%) in 1 survivor, and 20 (18%) in no survivors. Of the 235 fetuses, 154 (65.5%) survived to follow-up. Survival increased from 59% in 2006–2008 to 73% in 2015–2017. 90/154 (58%) survivors were followed up at a mean age of 7.5 [SD 3.0] years. Based on parental interview and Child Behaviour Checklist data, 28/90 (31%) participants were assessed as having neurodevelopmental impairment, 27 of mild-moderate severity and 1 severe. Speech/language disorders, attention deficit (hyperactivity) disorders, and fine motor impairment were most common. Neonatal length of stay conferred the highest risk of impairment. CONCLUSION: Substantial variation exists between fetal therapy services in the type and length of neonatal follow-up following fetoscopic laser coagulation, contributing to a lack of data on long-term outcomes. The findings from this study support increasingly urgent calls to undertake systematic and sustained follow-up of fetoscopic laser coagulation survivors until school age. Information from this study may assist parents in their decision-making when offered fetal surgery. Importantly, it highlights a group for targeted surveillance and early intervention.
format Online
Article
Text
id pubmed-10540356
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105403562023-09-30 Developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome Guzys, Angela Reid, Susan M. Bolch, Christie Reddihough, Dinah S. Teoh, Mark Palma-Dias, Ricardo Fung, Alison Cole, Stephen Hodges, Ryan Fahey, Michael Walker, Susan P. BMC Pregnancy Childbirth Research BACKGROUND: Fetoscopic laser coagulation of placental anastomoses reverses the pathological process in twin-to-twin transfusion syndrome, thereby increasing survival, but there are a paucity of studies addressing long-term neurodevelopmental outcome of survivors. This study aimed to ascertain the presence of neurodevelopmental disabilities in child survivors of monochorionic pregnancies managed by placental laser photocoagulation in the Australian state of Victoria. METHODS: All pregnancies undergoing placental laser photocoagulation with the Victorian Fetal Therapy Service between 2006–2017 were included. Information on each surviving child, including demographics, perinatal course, and developmental progress was collected from parents, and consent was sought to complete the Child Behaviour Checklist. Interviewers evaluated whether this information was consistent with a diagnosis of any of 14 neurodevelopmental conditions. A three-tiered outcome measure was allocated for each child: (1) unimpaired or developmentally normal, (2) mild or moderate neurological impairment, or (3) severe neurological impairment. Clinical predictors for adverse outcome were identified. RESULTS: Of 116 pregnancies (113 twin, 3 triplet), 96 (83%) resulted in 1 + surviving fetuses. 57/113 (50%) twin pregnancies resulted in 2 survivors, 36 (32%) in 1 survivor, and 20 (18%) in no survivors. Of the 235 fetuses, 154 (65.5%) survived to follow-up. Survival increased from 59% in 2006–2008 to 73% in 2015–2017. 90/154 (58%) survivors were followed up at a mean age of 7.5 [SD 3.0] years. Based on parental interview and Child Behaviour Checklist data, 28/90 (31%) participants were assessed as having neurodevelopmental impairment, 27 of mild-moderate severity and 1 severe. Speech/language disorders, attention deficit (hyperactivity) disorders, and fine motor impairment were most common. Neonatal length of stay conferred the highest risk of impairment. CONCLUSION: Substantial variation exists between fetal therapy services in the type and length of neonatal follow-up following fetoscopic laser coagulation, contributing to a lack of data on long-term outcomes. The findings from this study support increasingly urgent calls to undertake systematic and sustained follow-up of fetoscopic laser coagulation survivors until school age. Information from this study may assist parents in their decision-making when offered fetal surgery. Importantly, it highlights a group for targeted surveillance and early intervention. BioMed Central 2023-09-28 /pmc/articles/PMC10540356/ /pubmed/37770827 http://dx.doi.org/10.1186/s12884-023-05997-5 Text en © Crown 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Guzys, Angela
Reid, Susan M.
Bolch, Christie
Reddihough, Dinah S.
Teoh, Mark
Palma-Dias, Ricardo
Fung, Alison
Cole, Stephen
Hodges, Ryan
Fahey, Michael
Walker, Susan P.
Developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome
title Developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome
title_full Developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome
title_fullStr Developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome
title_full_unstemmed Developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome
title_short Developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome
title_sort developmental outcomes for survivors of placental laser photocoagulation for the management of twin-to-twin transfusion syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540356/
https://www.ncbi.nlm.nih.gov/pubmed/37770827
http://dx.doi.org/10.1186/s12884-023-05997-5
work_keys_str_mv AT guzysangela developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT reidsusanm developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT bolchchristie developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT reddihoughdinahs developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT teohmark developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT palmadiasricardo developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT fungalison developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT colestephen developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT hodgesryan developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT faheymichael developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome
AT walkersusanp developmentaloutcomesforsurvivorsofplacentallaserphotocoagulationforthemanagementoftwintotwintransfusionsyndrome